This study involves a controlled trial of an optimized version of a weight management and physical activity psycho-educational intervention (called MOVE!) with 200 obese and overweight veterans with serious mental illness.

This study involves a controlled trial of an optimized version of a weight management and physical activity psycho-educational intervention (called MOVE!) for overweight and obese Veterans with serious mental illness. The study hypothesizes that MOVE! will result in weight loss and improved indicators of cardiovascular risk when compared to usual care. Medical outcomes are proportion achieving 4% or higher weight loss, mean weight loss, and reductions in cardiovascular risk (blood pressure, glucose and serum lipids). Psychosocial outcomes are general health, psychiatric functioning, quality of life, and self-esteem and medication adherence. Mediators include physical activity, dietary management, self-efficacy, and motivation/readiness to change. The intervention involves a well specified combination of individualized and group based services and draws on evidence based techniques and materials that are currently well packaged in an existing VA program called MOVE! The Comparison condition is operationalized as usual treatment plus monthly weight measurements and distribution of educational brochures regarding diet and exercise.

Inclusion Criteria:

• DSM- IV diagnosis of schizophrenia spectrum disorders OR a DSM-IV diagnosis of other severe mental disorder including bipolar disorder, major depression, or severe anxiety disorder;
• Age between 18-64;
• No psychiatric hospitalization in 3-month period prior to enrollment;
• Community residency within 30 miles of either VA facility;
• A BMI of 25 or higher;
• Voluntary consent after receiving full information about the study;
• English speaking;
• Veteran of the armed forces

Exclusion Criteria:

• Active cancer other than non-melanoma skin cancer
• end stage chronic obstructive pulmonary disease
• end stage congestive heart failure
• end-stage neurological disorder
• problematic substance abuse as defined by provider
• end stage renal disease
• moderate to severe cognitive impairment (dementia, post-stroke)
• HIV positive with a CD4 count less than or equal to 350 within the last 6 months
• anorexia
• current pregnancy, currently nursing or planning to become pregnant in the next 6 months
• those living in long-term care facilities
• use in past 3 months of prescription pharmacological agents for weight loss
• no chart documented VA delivered medical primary care or general somatic care visit within the last 18 months
• most recent chart documented hematocrit level obtained within last six months is at or below 30%
• most recent chart documented creatinine level obtained within the last six months that is at or above 2.5
• most recent chart documented liver function tests obtained within the last six months exceeds twice the normal value for ALT, AST test in the Baltimore VA laboratory

Adverse Events were reviewed for this study, although none were observed during the research trial.